#AQUATICtrial
#AQUATICtrial In chronic coronary syndrome pts at high 🫀atherothrombotic risk on long-term oral anticoagulation (OAC), adding ASA
↑ CV events (HR 1.53), death (HR 1.72) & major bleeding (HR 3.35) without benefit.
OAC alone safer. Published in @nejm.org www.nejm.org/doi/full/10....
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | NEJM
The appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation remains unknown. We conducted a...
www.nejm.org
August 31, 2025 at 8:44 PM